Long-acting HIV shots appeal to many but uptake remains low

When it comes to HIV medication, many patients think they'd prefer an occasional injection over a daily pill, but uptake remains an issue, according to a Rutgers Health-led survey. When researchers surveyed 801 people living ...

New cellular target prevents hepatitis E infection

An international team of researchers has identified a promising new approach for treating infections with the Hepatitis E virus (HEV). At the center of the study is the drug Apilimod, which specifically blocks the entry of ...

What a 'post‑antibiotic era' could mean for modern medicine

Antibiotics are one of the greatest breakthroughs in medical history. They turned once-deadly infections into treatable illnesses and made modern health care possible. But bacteria are changing, and some of the drugs we have ...

Q&A: As ticks spread, so do the diseases they carry

Up-close tick encounters are nothing new to Peter Krause. As a tick-borne disease researcher, he's conducted fieldwork where these parasites live. After one trip to Block Island, off the coast of Rhode Island where ticks ...

page 4 from 40